Welcome to Medications.com

Teva Raises Guidance After Fourth-Quarter Net Jumps (Update1) - Bloomberg

Teva used this ``at risk'' strategy when it released Protonix and a version of Novartis AG's Lotrel heart medicine. ``Lotrel still has no competition, ...

http://www.bloomberg.com/apps/new... | Posted: Tue Feb 12 11:16:31 -0500 2008




© 2002-2007, Skylabs Inc.  |  About Us  |  Disclaimer/Terms of Use  |  Advertise  |  Contact Us  |  Site Map  |  Developed by: W3matter.com | Sleep Apnea